Sleep apnea affects an estimated 25% of adult men and 10% of adult women in the United States, making it one of the most prevalent chronic conditions in the country. It is also significantly underdiagnosed — many people with sleep apnea are unaware of it, and primary care physicians don't routinely screen for it. Understanding the symptoms, what diagnosis involves, and what treatment actually looks like is worth the effort for anyone who suspects it.
Obstructive sleep apnea (OSA, the most common form) occurs when the upper airway collapses partially or completely during sleep, interrupting breathing repeatedly throughout the night. These interruptions — which can number in the dozens to hundreds per hour in severe cases — cause brief arousals from sleep (often not consciously experienced) and oxygen desaturation. The result is severely fragmented sleep architecture even when total time in bed is adequate.
The health consequences of untreated sleep apnea extend well beyond daytime fatigue. Obstructive sleep apnea is independently associated with elevated cardiovascular disease risk, hypertension (which is frequently treatment-resistant until the apnea is addressed), type 2 diabetes, cognitive impairment, and depression. The cardiovascular consequences are the most well-documented and clinically serious — untreated severe sleep apnea approximately doubles the risk of cardiovascular events.
Loud snoring and witnessed breathing pauses during sleep are the symptoms most people associate with sleep apnea and are indeed reliable indicators. But many people with sleep apnea don't sleep with partners who witness these events, and the subjective experience of sleep apnea is often misattributed.
Excessive daytime sleepiness — falling asleep in sedentary situations (watching TV, reading, sitting in meetings) despite adequate time in bed — is the most significant functional symptom and is often attributed to lifestyle factors (not enough sleep, stress, boring activities) rather than sleep quality issues. Morning headaches on waking are another frequently missed symptom, resulting from overnight CO2 elevation during breathing interruptions. Waking frequently to urinate (nocturia) is less intuitively associated with sleep apnea but is documented as a consequence of the condition.
People without obesity can have sleep apnea. While obesity is the strongest modifiable risk factor for OSA, anatomical factors (jaw structure, tongue size, airway anatomy) mean that lean individuals with specific anatomy can have significant apnea.
The gold standard for sleep apnea diagnosis is polysomnography (PSG) — a sleep study conducted in a sleep laboratory with simultaneous monitoring of brain activity, breathing, oxygen saturation, heart rate, and limb movement. Home sleep apnea tests (HSAT) are a less comprehensive alternative that measure breathing and oxygen saturation during home sleep. HSATs are appropriate for diagnosing uncomplicated OSA in appropriate patients; they miss central sleep apnea and some periodic limb movement disorders that PSG would detect.
The Apnea-Hypopnea Index (AHI) — the number of breathing interruptions per hour of sleep — is the primary diagnostic metric. Mild OSA is AHI 5-14; moderate is 15-29; severe is AHI 30+. Treatment recommendations are influenced by AHI severity but also by symptoms — a person with AHI 10 and significant daytime impairment may warrant treatment that someone with AHI 10 and no daytime symptoms doesn't.
CPAP (Continuous Positive Airway Pressure) is the most effective treatment for moderate-to-severe OSA. A mask worn during sleep delivers pressurized air that keeps the airway open. CPAP is effective when used consistently — studies show dramatic improvements in daytime function, blood pressure, and cardiovascular risk with regular use. The challenge is adherence: the mask is uncomfortable for many users initially, and the pressurized air takes adjustment. Modern CPAP machines with auto-titrating pressure and heated humidification are significantly more comfortable than older generation equipment.
Oral appliances (mandibular advancement devices, fitted by a dentist specializing in sleep medicine) advance the lower jaw during sleep to maintain airway patency. They are less effective than CPAP for severe OSA but more comfortable, producing better real-world adherence in patients with mild-to-moderate OSA. For the subset of OSA patients who cannot tolerate CPAP, oral appliances are a clinically meaningful alternative.
Honest Bottom Line: Sleep apnea is substantially underdiagnosed and produces serious health consequences beyond fatigue — cardiovascular disease risk, hypertension, metabolic effects — that make untreated apnea a meaningful health concern rather than just a quality-of-life issue. Symptoms frequently missed: morning headaches, nocturia, daytime sleepiness attributed to lifestyle. Home sleep tests are adequate for diagnosing uncomplicated OSA; polysomnography is the gold standard. CPAP is the most effective treatment; oral appliances are a reasonable alternative for mild-to-moderate OSA in patients who cannot tolerate CPAP.

Sarah Mitchell is a health and wellness writer with a background in nutritional science and clinical psychology. With 8 years of experience translating complex medical research into actionable guidance, she covers eviden...